文献速递血栓与止血

免疫性血小板减少症(ITP)中的补体:补体在难治性ITP中的作用

Complement in immune thrombocytopenia (ITP): The role of complement in refractory ITP.
PubMed 文献 · Br J Haematol · 2023-01-01

本文综述补体在难治性免疫性血小板减少症(ITP)中的作用。ITP自身抗体多为IgG1亚类,可经经典途径激活补体,导致血小板直接破坏、C3b包被血小板经补体受体清除增强,以及骨髓巨核细胞补体损伤和无效血小板生成。一种经典补体途径抑制剂的近期早期临床试验在部分难治性ITP患者中显示疗效。

要点

  • ITP自身抗体多为IgG1亚类,可有效激活经典补体途径。
  • 抗体包被血小板经经典途径激活补体,导致直接破坏和C3b介导的清除增强。
  • 自身抗体与骨髓巨核细胞相互作用可致补体损伤和无效血小板生成。

核心结论

  • 本文综述补体在难治性ITP中的作用,经典补体途径抑制剂在部分难治性ITP患者中显示疗效。

研究设计与样本

  • 本文为综述,分析补体在难治性ITP中的作用。

主要发现

  • ITP患者大多数自身抗体为IgG1亚类,可有效激活经典补体途径。
  • 抗体包被血小板经经典途径启动补体活化,导致血小板直接破坏和C3b包被血小板经补体受体清除增强。
  • 自身抗体与骨髓巨核细胞类似相互作用可致补体损伤和无效血小板生成。
  • 一种经典补体途径抑制剂的近期早期临床试验在部分对常规免疫调节难治的ITP患者中显示疗效。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immune thrombocytopenia (ITP) is a disorder characterized by low platelets due to increased clearance and decreased platelet production. While ITP has been characterized as an acquired disorder of the adaptive immune system, the resulting platelet autoantibodies provide ancillary links to the innate immune system via antibody interaction with the complement system. Most autoantibodies in patients with ITP are of the IgG1 subclass, which can be potent activators of the classical complement pathway. Antibody-coated platelets can initiate complement activation via the classical pathway leading to both direct platelet destruction and enhanced clearance of C3b-coated platelets by complement receptors. Similar autoantibody interactions with bone marrow megakaryocytes can also result in complement injury and ineffective thrombopoiesis. The development of novel therapeutic complement inhibitors has revived interest in the role of complement in autoantibody-mediated disorders, such as ITP. A recent early-phase clinical trial of a classical complement pathway inhibitor has demonstrated efficacy in a subset of ITP patients refractory to conventional immune modulation. In this review, we will analyse the role of complement in refractory ITP.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Weitz IC, Liebman HA. Complement in immune thrombocytopenia (ITP): The role of complement in refractory ITP. Br J Haematol. 2023. PMID: 37735550. doi:10.1111/bjh.19070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。